Click Here to Chat on WhatsApp
+16312597728

(Get Answer)

Question





Based on the abstract below, please critique the study by answering the questions that follow. Please note that this abstract may no longer reflect current evidence-based practice, as newer anticoagulants are now sometimes used in place of warfarin.







ABSTRACT

TITLE: Cost Analysis of Outpatient Treatment of Deep Vein Thrombosis

BACKGROUND: When patients have the complication of deep vein thrombosis (DVT) after surgery, the standard anticoagulation treatment includes heparin—either intravenous unfractionated heparin (UFH) or a subcutaneous low-molecular-weight heparin (LMWH) product—in combination with warfarin. After the patient's international normalized ratio (INR) is greater than 2.0, the patient discontinues the heparin product but continues on oral warfarin for 3 to 6 months. LMWH products have been approved for outpatient use.

OBJECTIVE: The objective of this study was to retrospectively measure the costs of treating patients with uncomplicated DVT discharged with either oral warfarin alone or a combination of oral warfarin and LMWH.

METHODS: Medical and prescription claims for Health Plan X were assessed. Costs to the health plan for hospitalized patients discharged in 2006 with a diagnosis of uncomplicated DVT were included in the analysis, and their claims history was followed for 1 year after initial hospital discharge date.

RESULTS: Compared with patients discharged on warfarin alone, the outpatient pharmacy costs were, on average, $750 higher for the patients discharged on the LMWH and warfarin combination, but the average hospital length of stay was 2 days less, resulting in a savings, on average of $2,300 in hospitalization costs. Therefore, mean total costs to the health plan per patient were $1,550 less for patients discharged on combination therapy. One-year follow-up showed no differences in readmission rates due to DVT for the two groups of patients, indicating similar effectiveness.

CONCLUSIONS: Outpatient anticoagulation therapy for uncomplicated DVT with a combination of LMWH and warfarin had higher outpatient pharmacy costs but lower hospitalization costs compared with warfarin alone, which resulted in overall savings to Health Plan X.

Abstract Reference:

Rascati, Karen L. Essentials of Pharmacoeconomics, Wolters Kluwer, 2013. ProQuest Ebook Central, https://ebookcentral-proquest-com.proxy.lib.ohio-state.edu/lib/ohiostate-ebooks/detail.action?docID=4625043.)

Questions:

Was the title appropriate? Why or why not?

What was the objective of the study? Was this clear?

Were you able to determine the perspective? If so, what was it?

Which of the four types of pharmacoeconomic analyses was conducted? Why?

Was either cost adjustment (also called annuitization) or discounting conducted? If so, was it appropriate?

Was a sensitivity analysis conducted? If so, on what estimate(s)?

Were limitations addressed? If so, what were they?

Was an unbiased summary of the results presented for the conclusion? Why or why not?
Step 1/2








1. Was the title appropriate? Why or why not?

Yes, the title is appropriate as it accurately reflects the objective of the study which is to measure the costs of treating patients with deep vein thrombosis (DVT) in an outpatient setting.

2. What was the objective of the study? Was this clear?

The objective of the study was to retrospectively measure the costs of treating patients with uncomplicated DVT discharged with either oral warfarin alone or a combination of oral warfarin and low-molecular-weight heparin (LMWH). This objective is clear from the abstract.

3. Were you able to determine the perspective? If so, what was it?

Yes, the perspective of the study is the cost analysis from the health plan's point of view, as medical and prescription claims for

Expert Answer

Question

Based on the abstract below, please critique the study by answering the questions that follow. Please note that this abstract may no longer reflect current evidence-based practice, as newer anticoagulants are now sometimes used in place of warfarin.
ABSTRACT TITLE: Cost Analysis of Outpatient Treatment of Deep Vein Thrombosis BACKGROUND: When patients have the complication of deep vein thrombosis (DVT) after surgery, the standard anticoagulation treatment includes heparin—either intravenous unfractionated heparin (UFH) or a subcutaneous low-molecular-weight heparin (LMWH) product—in combination with warfarin. After the patient's international normalized ratio (INR) is greater than 2.0, the patient discontinues the heparin product but continues on oral warfarin for 3 to 6 months. LMWH products have been approved for outpatient use. OBJECTIVE: The objective of this study was to retrospectively measure the costs of treating patients with uncomplicated DVT discharged with either oral warfarin alone or a combination of oral warfarin and LMWH. METHODS: Medical and prescription claims for Health Plan X were assessed. Costs to the health plan for hospitalized patients discharged in 2006 with a diagnosis of uncomplicated DVT were included in the analysis, and their claims history was followed for 1 year after initial hospital discharge date. RESULTS: Compared with patients discharged on warfarin alone, the outpatient pharmacy costs were, on average, $750 higher for the patients discharged on the LMWH and warfarin combination, but the average hospital length of stay was 2 days less, resulting in a savings, on average of $2,300 in hospitalization costs. Therefore, mean total costs to the health plan per patient were $1,550 less for patients discharged on combination therapy. One-year follow-up showed no differences in readmission rates due to DVT for the two groups of patients, indicating similar effectiveness. CONCLUSIONS: Outpatient anticoagulation therapy for uncomplicated DVT with a combination of LMWH and warfarin had higher outpatient pharmacy costs but lower hospitalization costs compared with warfarin alone, which resulted in overall savings to Health Plan X. Abstract Reference: Rascati, Karen L. Essentials of Pharmacoeconomics, Wolters Kluwer, 2013. ProQuest Ebook Central, https://ebookcentral-proquest-com.proxy.lib.ohio-state.edu/lib/ohiostate-ebooks/detail.action?docID=4625043.) Questions: Was the title appropriate? Why or why not? What was the objective of the study? Was this clear? Were you able to determine the perspective? If so, what was it? Which of the four types of pharmacoeconomic analyses was conducted? Why? Was either cost adjustment (also called annuitization) or discounting conducted? If so, was it appropriate? Was a sensitivity analysis conducted? If so, on what estimate(s)? Were limitations addressed? If so, what were they? Was an unbiased summary of the results presented for the conclusion? Why or why not?
Step 1/2
1. Was the title appropriate? Why or why not?
Yes, the title is appropriate as it accurately reflects the objective of the study which is to measure the costs of treating patients with deep vein thrombosis (DVT) in an outpatient setting.
2. What was the objective of the study? Was this clear?
The objective of the study was to retrospectively measure the costs of treating patients with uncomplicated DVT discharged with either oral warfarin alone or a combination of oral warfarin and low-molecular-weight heparin (LMWH). This objective is clear from the abstract.
3. Were you able to determine the perspective? If so, what was it?
Yes, the perspective of the study is the cost analysis from the health plan's point of view, as medical and prescription claims for "Health Plan X" were assessed and the costs to the health plan were analyzed.
4. Which of the four types of pharmacoeconomic analyses was conducted? Why?
The type of pharmacoeconomic analysis conducted in this study is cost analysis, which measures the cost of an intervention in comparison to another intervention or to no intervention at all. The study was conducted to determine the cost savings to Health Plan X from the combination therapy of LMWH and warfarin compared to warfarin alone.
Step 2/2
5. Was either cost adjustment (also called annuitization) or discounting conducted? If so, was it appropriate?
The abstract does not mention whether cost adjustment or discounting was conducted, so it cannot be determined whether it was appropriate or not.
6. Was a sensitivity analysis conducted? If so, on what estimate(s)?
The abstract does not mention a sensitivity analysis being conducted, so it cannot be determined what estimate(s) it was performed on.
7. Were limitations addressed? If so, what were they?
The abstract does not mention any limitations being addressed, so it cannot be determined what the limitations of the study were.
8. Was an unbiased summary of the results presented for the conclusion? Why or why not?
Yes, an unbiased summary of the results was presented in the conclusion, stating that the combination therapy of LMWH and warfarin had higher outpatient pharmacy costs but lower hospitalization costs compared to warfarin alone, resulting in overall savings to Health Plan X.
Final answer
1. Was the title appropriate? Why or why not?
Yes, the title is appropriate as it accurately reflects the objective of the study which is to measure the costs of treating patients with deep vein thrombosis (DVT) in an outpatient setting.
2. What was the objective of the study? Was this clear?
The objective of the study was to retrospectively measure the costs of treating patients with uncomplicated DVT discharged with either oral warfarin alone or a combination of oral warfarin and low-molecular-weight heparin (LMWH). This objective is clear from the abstract.
3. Were you able to determine the perspective? If so, what was it?
Yes, the perspective of the study is the cost analysis from the health plan's point of view, as medical and prescription claims for "Health Plan X" were assessed and the costs to the health plan were analyzed.
4. Which of the four types of pharmacoeconomic analyses was conducted? Why?
The type of pharmacoeconomic analysis conducted in this study is cost analysis, which measures the cost of an intervention in comparison to another intervention or to no intervention at all. The study was conducted to determine the cost savings to Health Plan X from the combination therapy of LMWH and warfarin compared to warfarin alone.
5. Was either cost adjustment (also called annuitization) or discounting conducted? If so, was it appropriate?
The abstract does not mention whether cost adjustment or discounting was conducted, so it cannot be determined whether it was appropriate or not.
6. Was a sensitivity analysis conducted? If so, on what estimate(s)?
The abstract does not mention a sensitivity analysis being conducted, so it cannot be determined what estimate(s) it was performed on.
7. Were limitations addressed? If so, what were they?
The abstract does not mention any limitations being addressed, so it cannot be determined what the limitations of the study were.
8. Was an unbiased summary of the results presented for the conclusion? Why or why not?
Yes, an unbiased summary of the results was presented in the conclusion, stating that the combination therapy of LMWH and warfarin had higher outpatient pharmacy costs but lower hospitalization costs compared to warfarin alone, resulting in overall savings to Health Plan X.

This question has already been tackled by one of our writers and a good grade recorded. You can equally get high grades by simply making your order for this or any other school assignment that you may have.

Every Student Buys Essays from us, here is why!

Pressed for time to complete assignments or when you feel like you cannot write, you can purchase an essay on our website. Some students also want model papers to use as samples when revising or writing. There are also students who approach our essay writing service to beat deadlines. We handle every type of homework, assignment, and academic writing tasks. You can buy college essays and other assignments here. At a glance, here are some reasons students prefer our website.

100% Original Essays and Papers

You can be sure that you are getting a paper that is custom written based on your instructions. We do not sell papers that are pre-written. Instead, we write every essay from scratch. When you say “write my essay,” we respond by giving you a paper that is 100% original and free of any plagiarism. The essays you purchase from us have never been sold anywhere.

Flexible & Affordable Prices

It does not cost a fortune to get academic writing help on our website. If you have a question from class, place an order, get a discount, and get cheap essay writing services. What you see as the price is what you pay for. There are no any hidden charges. If you need urgent papers, they might cost a little more, but the price is worth the quality you get in the end. Hire a professional academic writer beginning from $13 a page.

Anonymity, Privacy, and Confidentiality

No one will ever know that you purchased an essay or assignment from our website. The essays you buy from us are written by experts. Your data is only used to coordinate the essay writing services you get. No one can access your personal information and data. Go ahead and order an essay from our website. It is safe, secure, and convenient.

Order a Unique Copy of this Assignment
275 Words

By placing an order you agree to our terms of service

Place Order »